Related Experiment Video
Updated: Aug 9, 2026

Generation of Multivirus-specific T Cells to Prevent/treat Viral Infections after Allogeneic Hematopoietic Stem Cell Transplant
Published on: May 27, 2011
[Current aspects of chemotherapy of sexually transmitted viral diseases]
1Katedra i Zakład Mikrobiologii Lekarskiej, Centrum Biostruktury, Akademia Medyczna w Warszawie.
Abstract:
In recent years, among all sexually transmitted infectious agents, viral infections were indisputably at the head. In this group, genital herpes is one of the substantial infections. Acyclovir, valcyclovir and famcyclovir are the compounds applied in the treatment of Herpes simplex infections. In the therapy with an application of alternative drugs, the possibility of foscarnet should be inquired. These drugs have precise documentation on an application in the treatment of herpetic symptoms of acute infections. However, they do not influence, in radical way, the prevention of relapse of the disease. In spite of their universal and generally accessible application, they also do not influence the interruption of transmission of infection. It seems, that in the nearest perspective, there are hopes associated with introduction of effective and active immunization or, less probable, an introduction of the drug or method of the treatment terminating latency.
Related Concept Videos
Retrovirus Life Cycles
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Sexually Transmitted Infections
Genital Herpes
Trichomoniasis
Antiviral Nucleoside Inhibitors

